An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)

NCT02997176 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Talazoparib

Sponsor

Pfizer

Collaborators

[object Object]